Journal Article Summary

The article investigates how genetic and epigenetic factors influence the effectiveness of risperidone, an antipsychotic medication commonly used to treat schizophrenia. Understanding these factors is crucial because patients often experience varying responses to the same medication, which can lead to prolonged treatment times and increased healthcare costs. By identifying specific biomarkers related to drug response, healthcare providers may be able to tailor treatments more effectively for individuals, ultimately improving patient outcomes.

The study involved 288 Chinese Han patients with schizophrenia, divided into two cohorts from Henan and Shanghai. Researchers used advanced genetic sequencing and methylation analysis to identify potential biomarkers associated with risperidone response. They discovered two significant genetic variants linked to treatment efficacy and identified several methylation sites in genes related to drug metabolism. A combined analysis of these genetic and epigenetic markers revealed a model that could help predict how well patients might respond to risperidone.

Despite these findings, the study has limitations, including a relatively small sample size and the need for further validation of the results in larger populations. Patients should be aware that while genetic and epigenetic testing may provide insights into treatment responses, these tests are not yet standard practice. It is important for individuals to discuss their treatment options and any concerns about medication efficacy with their healthcare providers to ensure they receive the most appropriate care.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Shi Y, Li M, Song C, Xu Q, Huo R, Shen L, Xing Q, Cui D, et al.. Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients. Translational Psychiatry 2017. DOI: 10.1038/tp.2017.143. PMID: 28696411. PMCID: PMC5538123.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]